Starting your investment journey may feel challenging, but you’re not alone. Finding the best stocks for beginners is a smart first step, and we’re here to make it easier. With the right choices, you can balance stability and growth, setting yourself up for long-term success. Plus, investing in beginner-friendly stocks helps you build confidence as you learn the ropes. Whether you’re looking at tech, healthcare, or dividend stocks, there are plenty of manageable options to explore. Keep reading to discover practical tips and recommendations to grow your portfolio and make informed decisions every step of the way.

Beginner Friendly Stocks to Buy Now

Top 10 Best Stocks for Beginners to Buy Now for Long-term

Looking to invest but not sure where to start? Our list of the Top 10 Best Stocks for Beginners to Buy Now for Long-term offers reliable options with great growth potential. These picks are ideal for new investors aiming to build wealth gradually, combining stability and opportunity in industries like tech, healthcare, and more. Start smart and watch your portfolio grow.

Innodata Inc. (INOD)

Innodata Inc. (INOD) is emerging as a key player in the rapidly expanding generative AI (GenAI) market, a sector that has seen significant investment from major technology companies. The company has carved out a niche by specializing in the provision of high-quality AI training data and developing innovative platforms that cater to the growing demand for AI-driven solutions. This strategic positioning has allowed Innodata to align itself with the broader industry trend of integrating AI into various business processes, making it a compelling choice for investors looking to capitalize on the AI boom.

Over the past year, Innodata has demonstrated remarkable performance, with its stock achieving an impressive 291.8% growth, significantly outpacing its sector peers. This robust performance reflects the market’s confidence in the company’s ability to deliver value in a competitive and fast-evolving industry. Looking ahead, analysts are optimistic about Innodata’s prospects, forecasting a 34.6% revenue growth for 2025. This growth projection is underpinned by the company’s continued focus on innovation and its ability to meet the increasing demand for AI solutions. The consensus among analysts is a “Buy” rating, further reinforcing the positive sentiment surrounding the stock.

From a valuation perspective, Innodata is trading at a price-to-sales (P/S) ratio of 5.01X, which may appear high at first glance. However, this premium valuation is justified by the company’s strong growth trajectory and its strategic position in a high-growth market. As of now, Innodata’s stock price stands at $37.08, with a market capitalization of $1.08 billion. These figures underscore the company’s growing prominence in the AI sector and its potential to deliver sustained value to its shareholders.

Natural Grocers by Vitamin Cottage Inc. (NGVC)

Natural Grocers by Vitamin Cottage Inc. (NGVC) is well-positioned within the consumer staples sector, capitalizing on the growing health-conscious trends among consumers. As a retailer specializing in organic and natural foods, NGVC has carved out a strong niche in a market that continues to see increasing demand for healthier and more sustainable food options. This focus on health and wellness has allowed the company to maintain a competitive edge, making it an attractive choice for investors seeking exposure to the organic food industry.

The stock has garnered a bullish sentiment among analysts, with a projected return on investment (ROI) of 24.31% in 2025. This optimism is driven by the company’s ability to align with consumer preferences and its consistent performance in a sector that is expected to experience steady growth. Analysts have forecasted a trading range for NGVC between $14.05 and $54.13 in 2025, reflecting the potential for significant upside as the company continues to expand its footprint and capitalize on market opportunities.

Currently, NGVC’s stock is priced at $43.54, with a market capitalization of $998.42 million. These figures highlight the company’s solid standing in the market and its potential for further growth as it continues to benefit from the increasing demand for organic and natural products. With its strong market position and favorable growth prospects, NGVC remains a compelling investment opportunity in the health and organic food sector.

Exelixis Inc. (EXEL)

Exelixis Inc. (EXEL) is a prominent player in the biotechnology sector, with a strong focus on oncology. The company is poised for significant growth, projecting revenues between $2.15 billion and $2.25 billion for 2025. This growth is primarily driven by its flagship drug, Cabometyx, which has established itself as a market leader in the treatment of renal cell carcinoma. Beyond Cabometyx, Exelixis is actively expanding its oncology portfolio, with promising candidates such as zanzalintinib, which are expected to further solidify its position in the cancer treatment market.

The company’s pipeline is robust, with multiple late-stage clinical trials currently underway. These include strategic collaborations with pharmaceutical giants like Merck and Bristol Myers, aimed at developing innovative treatments for challenging cancers such as pancreatic neuroendocrine tumors and head and neck squamous cell carcinoma. These partnerships and ongoing trials underscore Exelixis’s commitment to advancing cancer care and addressing unmet medical needs.

In terms of stock performance, Exelixis has delivered impressive results, with its shares surging by 58.7% over the past year. This strong performance reflects investor confidence in the company’s growth trajectory and its ability to deliver on its strategic objectives. Analysts have maintained a “Buy” rating for the stock, with a price target of $35.67, indicating further upside potential. Currently, Exelixis’s stock is priced at $33.15, with a market capitalization of $9.47 billion. These figures highlight the company’s strong market presence and its potential for continued growth as it leverages its innovative pipeline and strategic partnerships.

Rigetti Computing Inc. (RGTI)

Rigetti Computing Inc. (RGTI) stands out as a pioneering force in the emerging field of quantum computing. The company has ambitious plans to advance its technology, with the release of a 36-qubit system scheduled for mid-2025 and a more powerful 100-qubit system expected by the end of the year. These developments position Rigetti as a key player in the race to commercialize quantum computing. However, the technology remains in its early stages, with significant challenges such as scalability and error rates that need to be addressed before widespread adoption can occur.

The stock has experienced an extraordinary surge, with shares skyrocketing by 1,756% over the past year. This meteoric rise reflects heightened investor enthusiasm for quantum computing and Rigetti’s potential to lead in this transformative technology. However, analysts have raised concerns about the stock’s valuation, noting that its market capitalization is 480 times its estimated 2024 revenue. This has led to the stock being viewed as a speculative investment, heavily reliant on the long-term success of quantum computing.

Looking ahead, Rigetti’s outlook is a mix of promise and caution. The company boasts strong liquidity and a clear vision for its technological roadmap, which could position it as a leader in the quantum computing space. However, analysts are predicting a 74% decline in stock value, citing its current overvaluation and the inherent risks associated with investing in a nascent technology. As of now, Rigetti’s stock is priced at $13.17, with a market capitalization of $3.19 billion. While the company’s potential is undeniable, its stock remains a high-risk, high-reward play for investors betting on the future of quantum computing.

Rush Street Interactive Inc. (RSI)

Rush Street Interactive Inc. (RSI) operates as a leading digital gambling platform, capitalizing on the growing popularity of online gaming and sports betting. The company is forecasted to achieve an impressive annual revenue growth rate of 21.59%, significantly outperforming the gambling industry average. This growth is driven by its innovative platform and strong market presence, which continue to attract a growing user base. Analysts project earnings per share (EPS) to reach $0.37 in 2025, reflecting the company’s ability to scale its operations and improve profitability.

The stock currently holds a “Moderate Buy” rating, with a price target of $14.00, which is slightly below its current trading price of $14.58. This suggests that while the stock is fairly valued, its strong position in the rapidly expanding online gambling market makes it a compelling investment. With a market capitalization of $3.29 billion, RSI is well-positioned to capitalize on the increasing adoption of digital gambling platforms and the broader shift toward online entertainment.

Mercurity Fintech Holding Inc. (MFH)

Mercurity Fintech Holding Inc. (MFH) specializes in blockchain-based digital asset trading infrastructure, a sector that is gaining traction as blockchain technology becomes more integrated into financial systems. Despite its innovative focus, the stock has received a “Hold/Accumulate” rating due to mixed market signals, including a recent price drop of 0.426%. This short-term volatility reflects the challenges of operating in a nascent and highly dynamic industry.

However, analysts remain optimistic about the stock’s medium-term prospects, predicting a significant rise in value over the next three months. The projected price range of $11.92 to $19.11 highlights the potential for substantial returns, provided the company can navigate market challenges and capitalize on its technological strengths. Currently, MFH is trading at $7.01, with a market capitalization of $446.26 million, making it a speculative but potentially rewarding investment for those bullish on blockchain technology.

AbbVie Inc. (ABBV)

AbbVie Inc. (ABBV) is a pharmaceutical giant with a strong focus on immunology and oncology. The company is targeting $24 billion in sales from its flagship immunology drugs, Skyrizi and Rinvoq, by 2025. These drugs are expected to play a pivotal role in driving AbbVie’s total projected revenues of $59 billion for the year. With a robust pipeline of innovative treatments, AbbVie anticipates mid-single-digit revenue growth, underscoring its ability to sustain long-term performance.

Currently trading at $183.90, AbbVie boasts a market capitalization of $324.98 billion, reflecting its dominant position in the pharmaceutical industry. The company’s strong growth potential, supported by its leading immunology portfolio and ongoing pipeline developments, makes it a reliable choice for investors seeking exposure to the healthcare sector.

Applied Materials Inc. (AMAT)

Applied Materials Inc. (AMAT) is a global leader in semiconductor manufacturing equipment, benefiting from the increasing demand for advanced chips across various industries. Analysts predict a 2025 price range of $179.82 to $270.32, with an average target of $218.71, representing a 21.27% upside from its current price of $180.35. This growth is driven by the company’s ability to innovate and meet the evolving needs of the semiconductor industry.

The stock has a “Moderate Buy” rating from 22 analysts, with 15 recommending a “Buy.” With a market capitalization of $146.57 billion, Applied Materials is well-positioned to capitalize on the ongoing digital transformation and the growing demand for semiconductor technology.

Meta Platforms (META)

Meta Platforms (META) continues to redefine the digital landscape by leveraging artificial intelligence to enhance its ad business and diversify revenue streams. The company is investing heavily in initiatives like AI Studio and smart glasses, which are expected to drive future growth. Analysts have raised the 2025 price target to $725, citing strong ad revenue growth and the potential of its Threads platform to become a major player in social media.

Meta’s ad revenue grew by 18.7% year-over-year in Q3 2024, and Threads is projected to surpass X (formerly Twitter) in monthly users by 2025, potentially adding billions in revenue. Currently trading at $689.18, Meta has a market capitalization of $1.74 trillion, making it one of the most valuable companies globally. Its strong growth trajectory and innovative initiatives make it a top choice for investors seeking exposure to the tech sector.

Serve Robotics (SERV)

Serve Robotics is at the forefront of the autonomous delivery robot market, a sector poised for significant growth as logistics companies seek innovative solutions for last-mile delivery. While specific forecasts for 2025 are unavailable, the company is well-positioned to benefit from the increasing demand for efficient and cost-effective delivery systems.

Currently trading at $16.59, Serve Robotics has a market capitalization of $930.86 million. Its focus on cutting-edge technology and the growing adoption of autonomous delivery solutions make it a promising investment in the logistics and automation space.

Tips for Beginners on Best Stocks to Buy Now

1️⃣ Research stock market basics.
2️⃣ Define your investment goals.
3️⃣ Diversify your portfolio.
4️⃣ Know your risk tolerance.
5️⃣ Focus on long-term growth.
6️⃣ Start with small investments.
7️⃣ Choose well-known, stable companies.
8️⃣ Consider dividend-paying stocks.
9️⃣ Use trusted trading platforms.
🔟 Stay patient and disciplined.

Frequently Asked Questions

Which stock will grow the most by 2025?

Stocks in rapidly expanding industries like AI, renewable energy, or biotechnology have strong growth potential, but the outcome is subject to market trends and company performance.

What stocks are strong buys?

Stocks with consistent revenue, a clear growth strategy, and analyst endorsements as “Buy” are typically strong candidates. Look for well-established companies with proven track records and growth prospects.

Which stock is best for 5 years?

For five-year investments, consider companies with strong fundamentals, innovative products, and a presence in high-growth markets like technology or healthcare.

Where do I buy stocks?

Stocks can be purchased through online brokerages, investment apps, or traditional financial institutions that facilitate trading.

Which stock grows very fast?

Fast-growing stocks are often found in emerging sectors like technology, clean energy, or digital infrastructure. Such companies typically exhibit strong revenue growth but may carry higher risk.

Which stock is most profitable?

Profitable stocks are often tied to companies with steady earnings, high margins, and market dominance, often found in sectors like finance or pharmaceuticals.

What stocks will double in 2025?

Stocks with high upside potential in dynamic industries like AI, EVs, or renewable energy may double, but this depends on market performance and execution of business plans.

How do I pick my first stock to buy?

Start with companies you understand, look at consistent revenue growth, solid fundamentals, and reputable management. Diversify by picking a stock from a stable industry.

How to identify good stocks?

Assess financial health, revenue trends, market position, industry growth, and valuation. Tools like P/E ratios and analyst recommendations can also help.

What type of stock is best for beginners?

Dividend stocks are ideal for beginners due to their stability and regular income, helping to balance growth and risk in a portfolio.

Which are the Best growth stocks to buy now?

Growth stocks with strong potential often lie in sectors like technology, healthcare, and renewable energy, offering scalability and innovation.

Which are the Best stocks to buy now under $10?

Affordable stocks under $10 typically include smaller or newer companies; thorough research is crucial to find those with growth potential and financial stability.

Which are Cheap stocks to buy today?

Cheap stocks may involve undervalued or small-cap companies that show signs of long-term recovery or growth, but ensure you assess their fundamentals before investing.

Which are the Best stocks to invest in 2025?

Look for stocks in sectors poised for expansion, such as technology, AI, or clean energy, especially those with innovative business models and growth opportunities.

Which are the best stocks to buy now for short-term?

Short-term investments often include stocks benefiting from recent market trends or announcements, such as new product launches or earnings reports. Stay informed on market conditions.

Conclusion

Starting your investing journey might feel overwhelming, but with a bit of research and smart diversification, you’re on the right path. Focus on long-term growth and choose stable options that suit your goals. Remember, investing is a learning process,stay patient, keep growing your knowledge, and watch your portfolio thrive over time.

Disclaimer:

All information has been prepared by TraderFactor or partners. The information does not contain a record of TraderFactor or partner’s prices or an offer of or solicitation for a transaction in any financial instrument. No representation or warranty is given as to the accuracy or completeness of this information. Any material provided does not have regard to the specific investment objective and financial situation of any person who may read it. Past performance is not a reliable indicator of future performance.